Table of Contents

June 01, 2026; Volume 93, Issue 6
  • From the Editor

      • Pseudocellulitis, a vague term for a specific diagnostic challenge

        Brian F. Mandell, MD, PhD
        • Cleveland Clinic Journal of Medicine June 2026, 93 (6) 313-314;
        • DOI: https://doi.org/10.3949/ccjm.93b.06026
        • There are infectious, vascular, and inflammatory conditions that can mimic cellulitis sufficiently to prompt admission and initial treatment with intravenous antibiotics.

  • The Clinical Picture

      • Disseminated coccidioidomycosis masquerading as bacterial cellulitis

        Santana Maria Bachaalany, DO, Nelson Nicolasora, MD, Lindsay Ackerman, MD, Ghassan Ibrahim, MD and Trent Smith, MD
        • Cleveland Clinic Journal of Medicine June 2026, 93 (6) 321-323;
        • DOI: https://doi.org/10.3949/ccjm.93a.25096
        • The patient exhibited signs of sepsis along with progressive left breast erythema, induration, and pain.

  • Commentary

  • Symptoms to Diagnosis

      • Hematochezia in a patient with end-stage renal disease

        Brennan Gioe, MD, Conrad Fernandes, MD, E. Celia Marginean, MD and Stalin Subramanian, MD
        • Cleveland Clinic Journal of Medicine June 2026, 93 (6) 333-338;
        • DOI: https://doi.org/10.3949/ccjm.93a.25097
        • The patient developed gastrointestinal bleeding after being started on intravenous heparin following thrombectomy and angioplasty for acute limb ischemia.

  • Current Drug Therapy

  • Guidelines to Practice

      • When risks outweigh benefits: A review of the guideline on benzodiazepine tapering

        CME Image
        Hannah Snyder, MD, David Streem, MD, Akhil Anand, MD and Adele C. Viguera, MD
        • Cleveland Clinic Journal of Medicine June 2026, 93 (6) 347-352;
        • DOI: https://doi.org/10.3949/ccjm.93a.25102
        • The new joint clinical practice guideline provides a framework for deciding when tapering is appropriate and for implementing safe, patient-centered discontinuation strategies.

  • Review

      • TOC Icon

        Managing chronic kidney disease according to KDIGO risk categories: A primer for primary care

        Rodolfo J. Galindo, MD, Diana Soliman, MD, Joshua J. Neumiller, PharmD, Jay H. Shubrook, DO and Katherine R. Tuttle, MD
        • Cleveland Clinic Journal of Medicine June 2026, 93 (6) 353-365;
        • DOI: https://doi.org/10.3949/ccjm.93a.25072
        • The authors review the KDIGO guideline updates and provide a simplified treatment algorithm for non-nephrologists, focusing on medication sequencing and monitoring.

  • Editorial

  • Letter to the Editor